What is Citius Oncology, Inc.'s foreign operations?

Citius Oncology, Inc. (CTOR) reported foreign operations of -7.1% in Q3 2025.

What does foreign operations mean?

Quantifies the difference between the domestic statutory tax rate and the tax rates applicable to earnings generated in foreign jurisdictions. This is critical for assessing the tax efficiency of international operations.

Citius Oncology, Inc. CTOR Foreign operations

Foreign operations at other companies

3MMMM

5%+2.9pp

Hooker Furnishings CorporationHOFT

-0.1%0.0pp

TFX

TeleflexTFX

-66.6%-70.0pp

VirnetX Holding Corp VHC

-0%—

Charles River LaboratoriesCRL

11.1%+9.6pp

Trex CompanyTREX

0%—

Other financials

Income statement

See full

Revenue$1.7M—

Gross profit$1.3M—

Operating income-$28.6M-283%

Net income-$26.6M-244%

EPS (diluted)-$0.27-145%

Balance sheet

See full

Cash & equivalents$2.6M+2,350,466%

Total equity$35.3M-1.0%

Total assets$100.7M+10.1%

Cash flow

See full

Operating cash flow-$3.8M-179%

Valuation

See full

Market cap$60.45M-74.7%

Returns & leverage

See full

Return on equity-119.9%+46.7pp

Current ratio0.5×+0.1×

Where this comes from

Reported directly by Citius Oncology, Inc. in its filing.

Tagged under the XBRL concept us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential.

The official record: Citius Oncology, Inc.’s 10-K, filed December 23, 2025, on SEC EDGAR. View the filing →

Ask your AI about Citius Oncology, Inc.'s foreign operations.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Citius Oncology, Inc.'s foreign operations?: Citius Oncology, Inc. (CTOR) reported foreign operations of -7.1% in Q3 2025.
What does foreign operations mean?: Quantifies the difference between the domestic statutory tax rate and the tax rates applicable to earnings generated in foreign jurisdictions. This is critical for assessing the tax efficiency of international operations.